Modified quadruple therapy or bismuth-containing quadruple therapy in the first-line treatment of Helicobacter pylori in Turkey

Yozgat A., Kasapoglu B., Demirci S., Sokmen F. C.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, vol.113, no.7, pp.490-493, 2021 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 113 Issue: 7
  • Publication Date: 2021
  • Doi Number: 10.17235/reed.2020.7261/2020
  • Journal Name: REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals, DIALNET
  • Page Numbers: pp.490-493
  • Keywords: H. pylori, Quadruple therapy, First-line treatment, ANTIBIOTIC-RESISTANCE, ANTIMICROBIAL RESISTANCE, CLARITHROMYCIN, ERADICATION, METRONIDAZOLE, AMOXICILLIN, TRIAL
  • Lokman Hekim University Affiliated: No

Abstract

Aim: Helicobacter pylori (H. pylori) eradication is still an important issue in countries with high antibiotic resistance. This study aimed to compare the efficacy and safety of two bismuth-containing treatment modalities in H. pyloritreatment in Turkey.